Nervosave Therapeutics Overview
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Nervosave Therapeutics General Information
Description
Developer of a gene therapy platform designed to focus on nerve-related disorders such as peripheral neuropathies and neuropathic pain. The company develops therapy for CMT1A patients and beyond for all demyelinating diseases, and also develops discovery programs and acquires demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome, enabling patients with treatments for demyelinating peripheral neuropathies.
Contact Information
Website
www.nervosavetx.comCorporate Office
- 371 Rue du Professor Blayac
- Cédex
- 34080 Montpellier
- France
Corporate Office
- 371 Rue du Professor Blayac
- Cédex
- 34080 Montpellier
- France
Nervosave Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 28-Feb-2025 | Completed | Startup | |||
| 4. Accelerator/Incubator | 11-May-2023 | Completed | Startup | |||
| 3. Accelerator/Incubator | 24-Jan-2022 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup |
Nervosave Therapeutics Signals
Nervosave Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boost Invest MedVallée | Accelerator/Incubator | |||
| Westchester County Biosciences Accelerator | Accelerator/Incubator | |||
| SATT AxLR | Accelerator/Incubator | |||
| Deeptech Founders | Accelerator/Incubator | |||
| Business & Innovation Center | Accelerator/Incubator |
Nervosave Therapeutics FAQs
-
Where is Nervosave Therapeutics headquartered?
Nervosave Therapeutics is headquartered in Montpellier, France.
-
What is the size of Nervosave Therapeutics?
Nervosave Therapeutics has 4 total employees.
-
What industry is Nervosave Therapeutics in?
Nervosave Therapeutics’s primary industry is Drug Discovery.
-
Is Nervosave Therapeutics a private or public company?
Nervosave Therapeutics is a Private company.
-
What is Nervosave Therapeutics’s current revenue?
The current revenue for Nervosave Therapeutics is .
-
Who are Nervosave Therapeutics’s investors?
Boost Invest MedVallée, Westchester County Biosciences Accelerator, SATT AxLR, Deeptech Founders, and Business & Innovation Center have invested in Nervosave Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process